With new dementia cases expected to double in the United States by 2060, the therapy could be a difference maker. But ...
Biogen (NASDAQ:BIIB) said on Wednesday that the U.S. FDA has granted Fast Track designation to BIIB080, its antisense ...
A vaccination to prevent horribly painful shingles may offer an extra benefit: New research suggests it might lower the risk ...
Now, a study has found that low levels of LDL-C, or ‘bad’ cholesterol, may reduce the risk of developing dementia. Statins, a ...
A new study out of Stanford has presented the strongest evidence to date that a common vaccine could significantly reduce the ...
Worley was part of a team that showed how the loss of one of the two proteins used in the test disrupts synapses and leads to ...
The explanation of Alzheimer's, given the span of the disease, could become more of an ongoing process for the child rather ...
BIIB080 is an antisense oligonucleotide therapy designed to target microtubule-associated protein tau mRNA and reduce the production of tau.